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Abstract
In recent years, the prevalence of HIV-1 infection has been rapidly increasing among men who have sex with men (MSM).
However, it remains unknown how the host immune system responds to the infection in this population. We assessed the
quantity of HIV-specific CD8+ T-cell responses by using Elispot assay and their functionalities by measuring 5 CD8+ T-cell
evaluations (IL-2, MIP-1b, CD107a, TNF-a, IFN-c) with flow cytometry assays among 18 primarily and 37 early chronically HIV-
infected MSM. Our results demonstrated that subjects at early chronic phase developed HIV-specific CD8+ T-cell responses
with higher magnitudes and more diversified functionalities in comparison with those at primary infection. However,
populations with IL-2+ CD107a+ or in combination with other functionality failed to develop in parallel. The multifunctional
but not monofunctional HIV-specific CD8+ T cells were associated with higher CD4+ T -cell counts and lower viral loads.
These data revealed that prolonged infection from primary to early chronic infection could selectively increase the
functionalities of HIV-specific CD8+ T cells in HIV-infected MSM population, the failure to develop IL-2 and cytotoxic
functionalities in parallel may explain why the increased HIV-specific CD8+ T cells were unable to enhance the containment
of HIV-1 replication at the early chronic stage.
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Introduction
The HIV-specific CD8+ T-cell responses play an important role
in controlling viremia following initial HIV-1 infection, which is
supported by several important observations and correlative
studies. First, the appearance of cytotoxic CD8+ T lymphocytes
(CTLs) during acute HIV infection coincided with a decrease in
plasma viremia, and the experimental depletion of CD8+ T cells in
vivo resulted in a rapid increase in plasma viremia in the simian
immunodeficiency virus infected macaque model [1,2]. Second,
HIV-specific CD8+ T-cell mediated immunologic pressure was
often manifested by viral escape mutation [3,4], mutational escape
from HIV-specific CD8+ T cell responses was associated with
progressive increase in HIV plasma viremia [5]. Third, strong
correlations were observed between HLA heterogeneity and
survival advantage and between certain HLA class I alleles and
non-progressive HIV infection [6], for example, HIV-specific
CD8+T-cell responses restricted by HLA-B*57 were typically
associated with a non-progressive clinical consequence or at least a
slower disease progression [7,8].
Though cumulative evidences demonstrated a crucial role for
antiviral effects of CD8+ T cells, most HIV infected individuals
experience progressive loss of CD4+ T cells and fail to control
plasma viremia despite the presence of vigorous HIV-specific
CD8+ T-cell responses. A study using the most comprehensive
approaches has shown that the magnitude of HIV-specific CD8+
T-cell responses may not be a good surrogate for the host capacity
to control HIV replication [9]. The role of HIV-specific CD8+ T-
cell responses in chronic HIV infection may not be appropriately
assessed by simply quantifying the level of HIV-specific CD8+ T
cells. Recent data suggested that the breadth and the magnitude of
the CD8+ T cell responses directed against HIV-1 as measured by
IFN-c production did not correlate with HIV-1 viral loads [10–
13]. HIV-1 specific CD8+ T cells persisted in high numbers in
persons with untreated chronic progressive disease and no
quantitative differences in HIV-1 specific T cell responses were
observed between individuals with progressive and non-progres-
sive infection [9,10,14]. These findings suggested that CD8+ T cell
characteristics that determine differences in HIV-1 disease
outcomes might be of a qualitative rather than a quantitative
nature.
CD8+ T cells possess multiple functions, including exerting
cytolysis through direct interacting with or by releasing cytotoxic
molecules to target cells, producing cytokines to inhibit the viral
replication, or launching chemokines to block the viral entry into
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target cells. Therefore, the measurement of one CD8+ T-cell
function may not provide an adequate evaluation of CD8+ T-cell
quality. In an effort to better define CD8+T-cell quality, a
polychromatic flow cytometric assay to simultaneously assess 5
CD8+ T-cell functions, including gamma interferon (IFN-c),
tumor necrosis factor alpha (TNF-a), interleukin 2 (IL-2),
macrophage inflammatory protein 1b (MIP-1b), and CD107a (a
marker of degranulation), has been extensively employed in recent
clinical immunological studies and shown that HIV-specific
polyfunctional CD8+T cells appeared in high number in LTNPs
and viral controllers whereas monofunctional HIV-specific CD8+
T cells were associated with disease progression and failed to
contain viral replication [15].
Recent evidences demonstrated that polyfunctional HIV
epitope-specific CD8+ T cells were developed during primary
HIV-1 infection, but lost their polyfunctionalities and up-regulated
programmed death 1 (PD-1) expression in response to persistent
viremic infection [16]. However, viral mutational escape consis-
tently occurs during HIV infection and results in the appearance
of new epitopes and its-specific CD8+T cell responses [17].
Theoretically, the newly developed epitope-specific CD8+T cells
possess multifunctions, therefore, it could be speculated that a
mixture of polyfunctional epitope-specific CD8+T cells against
newly emerged epitopes with less or even mono-functional
epitope-specific CD8+T cells targeting at conserved epitopes
should be observed during HIV infection. Given HIV infection
causes a progressive damage to host immune system and the
accumulation of monofunctional CD8+ T cells, the consequence of
dynamic balance between polyfunctional and monofunctional
CD8+ T cells is determined by the disease progression and
infection time. With the deterioration of host immune system, the
polyfunctional CD8+ T cells will wane over time and the
monofunctional CD8+T cells will be likely to overweigh the
polyfunctional CD8+T cells. Although it is known that the epitope-
specific CD8+ T cells developed multiple functionalities during
primary HIV infection and gradually lose their functionalities with
the progression into chronic stages, however, with the addition of
the newly developed epitope-specific CD8+ T cells with multiple
functionalities during chronic infection, the overall pictures of total
CD8+ T cell responses will be different from the epitope-specific
CD8+ T cell responses [16], and may more relevant to viral
control during HIV-1 chronic infection.
We performed the polychromatic flow cytometric assay as
described above in peptide-stimulated peripheral blood CD8+ T
cells derived from the men who have sex with men (MSM)
population, and the functionalities of HIV-specific CD8+ T cells
were compared between the primarily infected individuals (,6
months) and early chronically infected subjects (12–36 months) to
determine the evolution of bulk HIV-specific CD8+ T cell
functionality at this early stage of HIV-1 infection.
Results
Subject Characteristics
The medians of blood CD4+ T and CD8+ T-cell counts, of
plasma viral loads, of ages and of infection time for the primary
infection (N = 18) and early chronic infection (N = 37) groups were
summarized in Table 1. The 18 subjects in HIV primary infection
group were infected for a median of 126.5 days (ranged from 47
and to 155 days) whereas those in the chronic phase were infected
for 16 months (ranged from 12 to 36 months). Among those
subjects in primary infection group, the ages ranged from 21 to 34
years with the median at 26.5 years, CD4+ T-cell counts ranged
between 94 and 539 cells/ml with the median at 400 cells/ml and
2.70–6.79 log10 HIV-1 RNA copies/ml for viral loads with the
median at 4.96 log10 HIV-1 RNA copies/ml. For thirty-seven
subjects in early chronic HIV-1 infected group, the ages ranged
between 20 and 52 years old with the median at 30 years old,
CD4+ T-cell counts ranged 109–848 cells/ml with the median at
366 cells/ml, and viral loads ranged 2.70 to 6.71 log10 HIV-1 RNA
copies/ml with the median plasma viral load at 4.71 log10 HIV-1
RNA copies/ml.
Comparison of HIV-specific IFN-c-secreting T Cell
Responses between Primary and Early Chronic HIV-
infected Groups in Response Breadth, Frequency and
Magnitude
An IFN-c based Elispot assay was employed to quantify HIV-
specific CD8+ T cells, and the response breadth, the responding
frequency and the magnitude of HIV-specific CD8+ T cells for
each peptide pool were compared between primary infection and
early chronic infection groups. As shown in Fig. 1a, the response
breadth as defined by the number of peptide pools able to raise
positive HIV-specific CD8+ T cells was significantly higher in early
chronic infection group than the primary infection group (ranged
5–16 peptide pools with the median at 12 for early chronic
infection group and 1–17 peptide pools with the median at 10 for
the primary infection group, p = 0.022), suggesting that the
prolonged HIV-infection could stimulate the host immune system
to recognize new antigenic peptide pools and thereby broaden the
HIV-specific CD8+ T-cell responses. These data were further
supported by the observation that the overall responding
frequency to 17 peptide pools in early chronic infection group
was significantly higher than that in primary infection group
(Fig.1b), a dramatic increase in recognition was unambiguously
observed for peptide pools of Pol2, Pol4, Pol5, Env3, Env5 and
Tat+Rev; Interestingly, only slight increase was observed for the
most frequently recognized pools of Gag2, Env2 and Nef with the
responding frequencies at 92.7%, 87.3% and 90.9%, respectively,
indicating epitopes in those pools are highly immunogenic and
able to mount efficient recognition at the primary infection phase
(Fig. 1b). Though a trend of increase in the number of HIV-
specific CD8+ T cells was observed on the majority of peptide
pools, a significant increase was mainly identified on those peptide
pools with dramatic increase of recognition as described above and
Nef peptide pool (p,0.05) (Figure S1). Overall, these data
suggested that during the transition from primary infection to
early chronic infection, HIV-specific CD8+ T cells were expanded
in both the breadth and magnitude.
Functionalities of HIV-specific CD8+T Cells During the
Primary and Early Chronic Infection
We next determined the functionalities of HIV-specific CD8+T
cells during primary and early chronic infection. Our data in Fig. 1
have demonstrated that Gag1, Gag2, Pol4, Pol5, Env2, Env3, Nef
and Tat+Rev peptide pools are the most predominant peptide
pools, therefore, we determined the functionalities of HIV-specific
CD8+T cells against those peptide pools. A polychromatic flow
cytometric assay was employed to simultaneously measure
CD107a mobilization, IL-2, MIP-1b, TNF-a, and IFN-c in
CD3+CD4-CD8+ T-cell population. The gating strategy is
illustrated in Fig. 2a with data from positive stimulation by PMA
plus ionomycin. In this subject, the stimulation of PMA and
ionomycin elicited high responses of all five functionalities as IL-2
(15.4%), MIP-1b (21.8%), CD107a (24.7%), TNF-a (24%) and
IFN-c (27.5%). The magnitude of each function response
for each peptide pool was assessed for all study subjects
CD8+ T Cell Functionality in HIV+ MSM
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and exemplified in Figure S2, summed into two groups of
primary and early chronic infection and then compared between
these two groups. The contribution of each function response
toward the total responses against one peptide pool was also
calculated and graphed.
As shown in Fig. 2b, all individual function responses for 5
functions were measurable for all 8 peptide pools, IFN-c
producing HIV-specific CD8+T cells was the predominant
responses in the stimulation of distinct peptide pools whereas IL-
2 producing HIV-specific CD8+ T cells was the lowest, TNF-a,
MIP-1b and CD107a expression were fluctuating between IFN-c
and IL-2 responses. When the immune responses in primary
infection group were compared with those in early chronic
infection group, we observed increased frequencies of HIV specific
CD8+ T-cell responses for all five functions in chronic infection in
all eight peptide pools (data not shown) and many differences
reached statistically significance as shown in Fig. 2c. Several
observations should be noticed between these two groups. First,
MIP-1b producing HIV-specific CD8+ T cells significantly
increased from primary to early chronic infection in 7 out of 8
peptide pools and represented the most frequently enhanced
responses, and then followed by IFN-c (6 out of 8 pools), TNF-a (5
of 8 pools), CD107a and IL-2 (both 3 of 8 pools). These data
suggested that different functional responses were not
proportionally increased, MIP-1b and IFN-c might
represented the long-lasting functions that could exist
in both newly developed HIV-specific CD8+ T cells and
previously raised CD8+ T cells (Fig. 2c) and thereby the
most significant enhancements were manifested in
those two functionalities, in contrast, CD107a and IL-2
might only exist in newly developed HIV-specific CD8+ T
cells and waned in previously activated CD8+ T cells.
Second, significant increase in all five functional responses was
only observed for Pol5 pool, and then followed by Env3 pool with
the increase in four functional responses. Similar to what we
described above in Elispot assay, our ICS data showed
that a significant fraction of study subjects recognized
these two pools only in the early chronic infection
(Figure S3); thus, a fraction of HIV-specific CD8+ T cells
against these two pools may represent newly developed immune
responses and thereby possess multiple functions. In contrast, less
diversified increases were observed in the most immunogenic
pools, including Gag2, Env2 and Nef since the majority of HIV-
specific CD8+T cells have been developed in the primary infection
and some may have been undergone functional attenuation.
Overall, our flow cytometric data supported our Elispot data and
demonstrated that different functional responses were expanded
during the transition from primary to early chronic infection, and
the development of skewed functionalities of HIV-specific CTLs
may have occurred at this early stage.
Polyfunctional HIV-specific CD8+T Cells in Primary and
Early Chronic Infection
On the basis of the expression of each of the five molecules
examined, thirty-one different unique subsets of CD8+ T cells
could be defined, including 5 single functional, 10 dual and 10
triple functional, 5 four functional and 1 five functional subsets.
Although the stimulation of PMA and ionomycin does produce
CD8+ T cells with four or five functions (Fig. 3a and
exemplified in Figure S4), the cell subsets with four or five
functions were not observed in our study subjects after antigenic
stimulation, consequently, 25 CD8+ T-cell subsets were identified
and quantified in our study. To determine the dynamic changes of
polyfunctional HIV-specific CD8+ T cells, we compared the 25
subsets of HIV-specific CD8+ T cells between primary and early
chronic infection groups for all 8 peptide pools. As shown in
Fig. 3b, 21 out of 25 subsets of HIV-specific CD8+ T cells against
Pol5 pool were significantly higher in early chronic infection group
than that in primary infection group, including eight subsets
featured with IFN-c or MIP-1b producing subsets (MIP-1b+,
TNF-a+, IFN-c+, MIP-1b+TNF-a+, MIP-1b+IFN-c+, TNF-
a+IFN-c+, CD107a+IFN-c+ and MIP-1b+CD107a+IFN-c+) with
the most significantly increase (p,0.001), eight subsets featured
with CD107a or IL-2 producing cells (CD107a+, IL-2+MIP-1b+,
MIP-1b+CD107a+, CD107a+TNF-a+, IL-2+MIP-1b+IFN-c+,
MIP-1b+CD107a+TNF-a+, MIP-1b+TNF-a+IFN-c+,
CD107a+TNF-a+IFN-c+) with p,0.01 and five subsets producing
IL-2 or in combination with other cytokines (IL-2+, IL-2+TNF-a+,
IL-2+IFN-c+, IL-2+MIP-1b+TNF-a+ and IL-2+TNF-a+IFN-c+)
with p,0.05. When HIV-specific CD8+ T cells against other 7
pools were examined, several observations should be noticed
(Fig. 3c). First, different increasing pattern of HIV-specific CD8+ T
cell subsets were observed among different pools, diversified
subsets were increased for peptide pools with significantly
increased recognition during early chronic infection from primary
infection, such as Pol4, Pol5 and Tat+Rev pools, and less subsets
were increased for immunogenic pools, including Gag2, Env2 and
Nef pools. Second, only multifunctional subsets are significantly
increased from primary infection to early chronic infection,
including 9 dual functional and 1 triple functional subsets
(p,0.01). Among all increased populations against those 7 pools,
14 out of 38 subsets are TNF-a+IFN-c+ or TNF-a+IFN-c+ in
combination with other functions, 8 subsets are MIP-1b+TNF-a+,
MIP-1b+IFN-c+ or MIP-1b+IFN-c+ in combination with other
functions, 16 subsets are IL-2+ or CD107a+ in combination with













Medians 26.5 400 836 4.96 126.5 days
Range 21–34 94–539 306–1383 2.70–6.79 47–155 days
Chronic infection
(N = 37)
Medians 30 366 957 4.71 16 months
Range 20–52 109–848 349–2392 2.70–6.71 12–36
months
aHIV duration refers to the time between HIV diagnosis and sampling date.
doi:10.1371/journal.pone.0044983.t001
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other functions. However, IL-2+CD107a+ subset or IL-
2+CD107a+ in combination with any one of IFN-c, MIP-1b and
TNF-a, only showed slight increase in early chronic infection
group and did not reach statistical significance with only one
exception in Env3 pool in which IL-2+CD107a+ subset reached
statistical significance but the magnitude was relatively low
comparing to other subset responses.
We also determined the composition of HIV-specific CD8+ T
cell immune responses by calculating the proportion of each
functional subset in global peptide pool-specific responses and
compared them between primary and early chronic infection
groups (Fig. 4a and 4b). As shown in Fig. 4a, the majority of Pol5-
specific CD8+ T cell immune responses in primary infection were
single functional and less functionally diversified, and both dual-
and triple-functional CD8+ T cells were significantly increased in
the early chronic infection group. This observation also held true
for all other 7 peptide pools (Fig. 4b).
Overall, our data demonstrated that the transition from primary
infection to early chronic infection resulted in the increase of
polyfunctional T cell subsets, including dual- and triple-functional
CD8+ T cell subsets; different functional subsets are dis-
proportionally increased, IL-2 and CD107a positive T cell subsets
are less increased comparing to INF-c or MIP-1b producing T cell
subsets, which may implicate that IL-2 and CD107a producing T
cell subsets are more sensitive to viral persistence. In addition, the
prolonged infection could result in the increase of functionality for
less immunogenic peptide pools.
The Association between Polyfunctional CD8+T Cells and
CD4+T-cell Counts, Plasma HIV-RNA, and Clinical
Outcomes
Previous studies have demonstrated a strong association
between the maintenance of polyfunctional HIV-specific CD8+T
cells and the containment of HIV-1 replication or disease
progression [15,18]. Here, we evaluate the functionality of HIV-
specific CD8+T cells and determined its association with the
disease progression represented by CD4+T cell counts and viral
replication expressed in viral loads. Since Gag2 peptide pool raised
HIV-1 specific CD8+T cell responses in 92.7% subjects in our
cohort and represented the most predominant HIV-1 specific
CD8+ T cell responses, it is reasonable to use Gag2-specific CD8+
T cell immune responses to define the association first. As shown
in Fig. 5a, an inverse association between the single functional T
cell responses and CD4+ T -cell counts (r = -0.35, p = 0.04) was
observed, in contrast, positive associations were identified between
the triple functional T cell responses and CD4+ T -cell counts
(r = 0.35, p = 0.03) and between the dual functional T cell
responses and CD4+ T-cell counts though the statistical signifi-
cance was not reached. In accordance with these observations
above, the increase in the single functional T cell responses was
coincided with the increase of plasma viral loads (r = 0.35,
p = 0.04) and an inverse association was observed between the
triple functional T cell responses and plasma viral loads
(r = 20.38, p = 0.02) and between the dual functional T cell
responses and plasma viral loads though the statistical significance
was not reached. In addition, by using Spearman rank correlation,
we also analyzed the associations between other seven HIV-
peptide pools specific CD8+ T -cell responses with CD4+T-cell
counts or plasma viral loads and similar patterns of associations
were observed (data not show). Overall, our data indicated that the
polyfunctional HIV-specific CD8+T cells were correlated to
slow disease progression and low viral replications
whereas the single functional HIV-specific CD8+T cells failed to
do so.
We further analyzed the contribution from each subset to the
good clinical outcomes by employing linear regression model
analysis. Good clinical outcomes were defined as an
inverse correlation between the magnitude of HIV-
specific CD8+ T-cell responses and viral loads, or a
positive correlation between the magnitude of HIV-
specific CD8+ T-cell responses and CD4+ T-cell counts.
As shown in Fig. 5b, a contribution rank of 3-functional subsets
.2-functional subsets .1-functional subsets was observed. All
three functional subsets could contribute to the good clinical
outcomes with the highest contributions from two subsets of IL-
2+CD107a+MIP-1b+ and IL-2+CD107a+IFN-c+ (8.89% for both),
then followed by other IL-2 or CD107a positive subsets. For dual
functional subsets, IL-2 in combination with other function ranked
as the highest contributor, then followed by subsets of CD107a in
combination with other functions. These data indicated that IL-2
producing and/or CD107a positive T cell subsets contributed the
most to the good clinical outcomes and thereby represent the most
powerful T cell subsets to contain viral replication and restrain the
disease progression.
Discussion
In this study, we examined and compared HIV-specific CD8+T-
cell functional hierarchy between HIV-1 primarily infected (,6
months) and early chronically infected MSM subjects (12-36
months) by using peptide derived from consensus B clade.
Our results suggested that the prolonged HIV-1 infection as shown
in early chronic phase group stimulated a broader HIV-specific
CD8+T cells with a higher magnitude and more diversified
functionalities. The kinetic profile of HIV-specific CD8+ T cells
varied among the immunogenic and less immunogenic peptide
pools, the prolonged stimulation is required for less immunogenic
epitopes to develop more functionally diversified and vigorous
HIV-specific CD8+T cells whereas less kinetic changes were
observed for immunogenic peptide pools. In addition, the
polyfunctional HIV-specific CD8+T cells were associated with
higher CD4+ T-cell counts and lower viral loads whereas the single
functional CD8+T cells were coincided with lower CD4+T-cell
counts and higher viral loads, indicating that different functional
HIV-specific CD8+ T cells are entitled with varied capacity to
control viral replication.
These data are for the first time to detail the overall functional
kinetic profiles of HIV-specific CD8+T cells in primarily and early
chronically HIV-infected MSM subjects and identify the changes
of HIV-specific CD8+T cells in functionalities, magnitude and
breadth during this transitional phase. In accordance with
previous reports [16], our data demonstrated that HIV infection
elicited polyfunctional HIV-specific CD8+T cells in early phase.
Figure 1. Comparison of the breadth, frequency and magnitude of responses (measured by IFN-c Elispot and given as SFC/106
PBMCs) between primary and early chronic phase of HIV infection. a. Summary of the number of peptide pools responded (breadth) per
individual in primary and early chronic HIV-infected individuals. b. Frequencies of each patient group responding to different peptide pools. The
percentages of each patient group mounted a positive response in an Elispot assay to each particular peptide pool were quantified, e.g. greater than
90% of all early chronic subjects mounted a positive response to the Nef pool. Statistically significant differences between groups (p,0.05) were
denoted by an asterisk.
doi:10.1371/journal.pone.0044983.g001
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However, prolonged HIV stimulation is a double-edged sword, on
one hand, it could increase the total number of polyfunctional
CD8+ T-cells and thereby may improve the control of viral
replication; on the other hand, it may lead to the functional
damage to HIV-specific CD8+ T cells due to the viral persistent
stimulation. Our data suggested that IL-2 producing function was
less developed and may have been partially damaged even in the
early chronic infection phase, this observation is conciliated with
previous observations that IL-2 producing subsets are mainly
appeared in early HIV-1 infection and in the relative healthy
immune environment of LTNPs [15,16,18-22]. Interestingly, the
function of degranulation (CD107a) seemed also to be partially
damaged in the early chronic infection phase in our cohort, which
could be resulted from two aspects. First, the persistent HIV
infection caused the continued degranulation of HIV-specific
CD8+ T cells, cytotoxic molecule producing subsets are usually
effector cells and less capable of proliferation [23], thereby prone
to be exhausted. Second, the gain of cytotoxic activities during the
differentiation of HIV-specific memory CD8+ T cells may depend
on the help of CD4+ T cells [24], which is waned over time during
HIV infection and thereby less cytotoxic molecule producing cells
are differentiated from HIV-specific memory CD8+ T cells with
prolonged HIV infection. Overall, the degranulation function is
less increased and the capacity for HIV-specific CD8+T cells to kill
HIV-infected target cells is blunted even in the early stage.
Therefore, the viral suppression during early phase of HIV
infection is depended on the balance between the gain of
polyfunctional HIV-specific CD8+T cells which could enhance
the capacity to contain the viral replication and the loss of
cytotoxic activities and proliferative capacity which attenuate the
ability to eliminate HIV-infected target cells, and with the elapse of
infection time this balance will progressively incline to the loss of
functions [25,26]. In addition, although total multiple functional
CD8+ T cells are increased from primary infection to the early
chronic infection, the accumulation of mutational viruses at this
stage resulted in the increase of specificities of epitopes and thereby
may reduced the multiple functional CD8+ T cells per epitope,
therefore, it is not surprised that the viral control from primary
infection to early chronic infection was not significantly improved.
Indeed, HIV infection not only causes the shift of the
functionalities of HIV-specific CD8+ T cells as shown in our
study above and in previous reports [16], the prolonged HIV
infection also results in the shift of the specificities of targeted
epitopes recognized by HIV-specific CD8+ T cells [27,28]. As
known, immune escaping mutation could occur within two weeks
after HIV infection and continued to do so thereafter [29,30]. The
immune escape from the attack by dominant T cell responses
could cause the exposure of subdominant epitopes to immune
system and thereby stimulates new HIV-specific CD8+ T cells
against those subdominant epitopes [17,28,31,32], which practi-
cally results in the increase in both the breadth and the magnitude
of HIV-specific CD8+T cells as observed in our study. Since the
hierarchy of epitope immunogenicity determines the timing for
activation during HIV infection and the immunogenicity varied
among different HIV epitopes/antigens, HIV-specific CD8+ T
cells against different epitopes/antigens could be developed at
different time, and immunogenic epitopes, usually designated as
dominant epitopes, could raise CD8+T-cell responses earlier than
that less immunogenic epitopes (subdominant epitopes)
[17,27,28,31]. This governing rule for CD8+ T-cell activation
determines that antigen/peptide pools containing dominant
epitopes will mount good immune responses in primary infection
and a significant further increase during prolonged infection will
be unlikely to occur, which is proven by the observation in this
study for Gag2 and Nef peptide pools. In contrast, antigen/
peptide pools containing subdominant epitopes will be likely to
raise new waves of immune responses during prolonged infection
and thereby a significant increase could be observed after primary
infection, as shown for peptide pools of Pol2, Pol4, Pol5, Env3,
Env5 and Tat+Rev in our study. However, the sequential
activation of CD8+T-cell responses against HIV infection could
cause problem and render HIV-1 avoid the simultaneous attack
from both immunogenic and less immunogenic epitope specific T
cell responses, and thereby allow the virus to implement a
sequential escaping strategy. This observation has important
implication for HIV-1 vaccine development, particularly a vaccine
strategy to simultaneously raise vigorous CD8+ T cells against both
immunogenic and less immunogenicity will be likely more
effective.
The functionality of subdominant epitope specific CD8+T cells
could be dramatically different from dominant epitope specific
CD8+T cells, because the lower avidity of subdominant epitope
with its corresponding T-cell receptors may impart CD8+ T cells
with discern intrinsic difference from dominant epitope [33]. In
addition, the reduced help from CD4+ T cells may also contribute
to the functional difference [25]. Though previous studies
demonstrated that CD8+ T cell specificity is one of critical
determinants in viral suppression [1-5,34], it remains to be
addressed whether this was attributed to the different functional-
ities for different CD8+T-cell specificity or to the varied mutational
damage to viral fitness for different CD8+ T-cell specificity or to
both. In summary, HIV-specific CD8+T-cell specificities are
continuously expanded over time by engaging in additional less
immunogenic epitopes, it remains to determine whether the
functional features of CD8+ T-cell specificity will influence their
capacity to suppress viral replication.
Polyfunctional HIV-specific CD8+ T cells have been associated
with good clinical outcomes [15,18]. The reason for this is that
polyfunctional T cells are fully armed and could use multiple tools
to tackle with HIV, and thereby more potent to suppress HIV
replication. In accordance with those observations, our data
corroborated that triple functional CD8+ T cells were significantly
Figure 2. Comparison of the magnitudes of different functional HIV-specific CD8+ T cells between primary and early chronic phase
of HIV infection. a. Gating scheme used for the identification of CD8+ T-cell responses. Data shown were from cells derived from one representative
patient, stimulated with PMA and ionomycin. Initial gating was performed on lymphocytes in a forward scatter of FSC-A versus FSC-H, and then FSC
vs SSC plot. CD3+ events were gated in the FSC versus CD3 plot prior to gating on CD3+CD8+ and CD3+CD4+ events. The resulting CD3+CD4-CD8+
population was further gated based on positivity for each of 5 functional responses including IL-2, MIP-1b, CD107a, TNF-a and IFN-c. b. The
frequencies of five distinct functions (color coded as shown) in the total CD8+ T-cell response against the indicated HIV peptide mix (x-axis) within 55
HIV-infected MSM. c. Comparison of the magnitude of different functional HIV-specific CD8+ T cells between primary and early chronic infection
groups. For simplicity, only significantly different populations were shown for Gag1, Gag2, Pol4, Pol5, Env2, Env3, Nef and Tat+Rev responses; no
significant differences were identified for those functions not shown. The responses from 55 HIV-infected MSM were standardized so that the profiles
could be compared irrespective of any frequency differences. Asterisks were placed above response pairs that were significantly different:
***p,0.001; **p,0.01 and *p,0.05. Each dot denoted a positive response for the function indicated at the bottom left. The box plots represented
the 10th, 25th, 75th, and 90th percentiles.
doi:10.1371/journal.pone.0044983.g002
CD8+ T Cell Functionality in HIV+ MSM
PLOS ONE | www.plosone.org 7 September 2012 | Volume 7 | Issue 9 | e44983
CD8+ T Cell Functionality in HIV+ MSM
PLOS ONE | www.plosone.org 8 September 2012 | Volume 7 | Issue 9 | e44983
correlated with higher CD4+T-cell counts and lower viral loads
whereas single functional CD8+T cells were unable to do so.
Furthermore, our data emphasized that IL-2 and CD107a dual
positive CD8+ T cells were among the most powerful T cells to
contain HIV replication. Since IL-2+CD8+ T cells have the
potential to proliferate independent of CD4+ T helper
[35], we speculated that although HIV infection resulted
in the depletion of CD4+ T cells, IL-2+CD107a+ CD8+ T
cells could proliferate despite the absence of help from
CD4+ T cells and thereby increase the number of HIV-
specific CD8+ T cells, and enhanced the capacity to
contain the viral replication.
Unexpectedly, we failed to identify HIV-specific CD8+ T cell
subsets with four and five functions which had been frequently
reported for LTNPs [15]. This is highly unlikely to be caused by
technical problems since all five functions are well defined in less
three functional subsets and the stimulation of PMA and
ionomycin does produce the CD8+ T cells with four or five
functions. It is unknown whether the limited functionalities are
MSM population specific or simply a further prolonged stimula-
tion is required for four and five functional T-cell subsets,
additional cohort studies should be performed to address this
question. In addition, both B clade and non-B clade HIV
viruses have been circulating in MSM populations [36],
the usage of consensus B derived peptides in our assay
quantified the cross-reactive CD8+ T cells and thereby
was likely to underestimate the magnitude of CD8+ T
cells responses, it remains unknown whether the
differences observed in this study will be applicable to
autologous CD8+ T cell responses.
Materials and Methods
Study Subjects
A cross-sectional study was conducted on 55 ART naı̈ve HIV-1-
positive MSM subjects. Eighteen individuals with HIV-1 primary
infection, defined as HIV-1 seroconversion within 6 months prior
to study enrollment, and thirty-seven subjects with early chronic
infection, defined as HIV-1 seroconversion for 12-36 months, were
recruited at Chaoyang CDC, Beijing, China. The study protocol
was evaluated and approved by both institutional review boards at
Shanghai Public Health Clinical Center and at the Chaoyang
CDC in Beijing, and all individuals provided written informed
consent for participation in the study.
Measurement of CD4+ T-cell Counts and Quantification
of Plasma Virus RNA
CD4+ T-cell counts and HIV-1 plasma virus RNA were
performed as described previously [37]. TruCountTM tubes and
TriTESTTM reagents (CD3-FITC/CD4-PE/CD45-PerCP) were
purchased from BD Biosciences for counting CD4+ T cells, all
procedures were followed as suggested by the manual. Real-time
RT-PCR was used to determine plasma viral loads by amplifica-
tion of a 102-bp segment of the HIV-1 gag gene. Briefly, Real-time
RT-PCR was performed using Real-time RT-PCR Kit (Shenzhen
PG Biotech Co. China) in 10 ml reaction volume, reactions were
performed in triplicate by using a COBAS AMPLICOR Analyzer.
Results were expressed as HIV-1 RNA copies/ml. The low
limitation was 500 copies/ml.
HIV Peptides and Antibodies
HIV-1 clade B consensus peptides obtained from NIH AIDS
Research and Reference Reagent Program, spanning the entire
HIV proteome. These peptides were 15-mers overlapping by 11
residues and were specific to consensus sequences for HIV-1 clade
B Gag (123 peptides, cat. no.8117), Pol (249 peptides, cat.
no. 6208), Env (211 peptides, cat. no. 9480), Tat (23 peptides, cat.
no.5138), Rev (27 peptides, cat. no. 6445), Nef (49 peptides, cat
no. 5189), Vif (46 peptides, cat no. 6446), Vpr (22 peptides, cat
no. 6447), and Vpu (19 peptides, cat no. 6444). All peptides were
synthesized as free acids and were more than 80% pure. Individual
lyophilized peptides were resolved into 50 ml DMSO (Sigma) and
950 ml RPMI 1640 at 1 mg/ml for the subsequent formulation of
peptide pools. Seventeen peptide pools were formulated, including
five pools for Pol (Pol1, Pol2, Pol3, Pol4, and Pol5; each contains
50 peptides except Pol5 contains 49 peptides) and for Env (Env1,
Env2, Env3, Env4, and Env5; each contains 42 peptides except
Env 5 contains 43 peptides), three for Gag (Gag1, Gag2, and
Gag3; each contains 41 peptides), one for Tat and Rev peptides
(Tat+Rev), one for Vpr and Vpu peptides (Vpr/u), one for Nef
and one for Vif. All peptide pools were stored at 280uC and the
final concentration for each peptide in the cultures was 2 mg/ml.
Directly conjugated antibodies for flow cytometric analysis were
used in the following fluorochrome combinations available from
commercial sources, including CD8-AmCyan, IL-2–phycoery-
thrin (PE), CD107a-Cy5-PE, TNF-a-allophycocyanin (APC),
CD4-Cy7-APC from BD Biosciences, CD3-ECD from Beckman
Coulter, IFN-c-Pacific Blue from eBioscience, MIP-1b-fluorescein
isothiocyanate (FITC) from R&D Systems. The unlabeled
costimulatory antibodies to CD28 (clone L293) and CD49d (clone
L25), were purchased from BD Biosciences.
Elispot Assay
Fresh PBMCs were used in an interferon (IFN)-c based Elispot
assay as described previously [37]. The number of specific T cells
was counted with ChampSpot IV Bioreader (Beijing SAGE
Creation Science, Beijing, China). The number of spot forming
cells (SFCs) was defined by subtracting the negative control values
(background) and the average number of spots in duplicate wells
per 106 PBMCs. The background was ,15 SFCs/106 PBMCs (3
spots/well at 200,000 PBMCs/well) in all cases and responses $50
IFN-c SFCs/106 PBMCs and .3 times of background were
considered as positive responses.
Figure 3. The functional profile of HIV-specific CD8+ T-cell populations during primary and early chronic HIV-1 infections. a. Detailed
magnitude of different functional CD8+ T cells after stimulation with PMA and ionomycin. The bar graph provided fine details on the magnitude of 31
different functional subpopulations; the 10th, 25th, 75th, and 90th percentiles and medians were shown. b. Detailed magnitude of different
functional CD8+ T cells after stimulation with HIV-Pol5 peptide pool. The bar graph provided fine details on the magnitude of 25 different functional
subpopulations (cell subsets with four or five functions were absent in our study); the 10th, 25th, 75th, and 90th percentiles and medians were
shown. c. Comparison of the magnitude of different functional HIV-specific CD8+ T cells against a certain peptide pool between primary and early
chronic infection groups. For simplicity, only significantly different subpopulations were shown for Gag1, Gag2, Pol4, Env2, Env3, Nef and Tat+Rev
responses; no significant differences were identified for those functional combinations not shown. In b and c, asterisks were placed above response
pairs that were significantly different: ***p,0.001, **p,0.01 and *p,0.05. Each dot denoted a positive response for the function indicated at the
bottom left.
doi:10.1371/journal.pone.0044983.g003
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Figure 4. Comparison of the weighted contribution of different functional CD8+ T-cell subsets to the global HIV peptide pool-
specific CD8+T-cell responses between primary and early chronic HIV-1 infection groups. a. Detailed weighted contribution of different
functional CD8+T subsets to the global CD8+ T response against HIV-Pol5 peptide pool. HIV-specific CD8+ T cells from early chronic infections have a
qualitatively different functional profile compared to primary infections. The box plots represent the 10th, 25th, 75th, and 90th percentiles of the
proportion of the respective functional responses toward the total CD8+ T-cell responses. Asterisks were placed above response pairs that were
significantly different: ***p,0.001; **p,0.01 and *p,0.05. Each dot denoted a positive response for the function indicated at the bottom left. b.
Proportions of triple producers (TP), double producers (DP) and single producers (SP) of CD8+ T cells responding to eight peptide pools during
primary and early chronic HIV-1 infections, were shown in the pie charts, respectively.
doi:10.1371/journal.pone.0044983.g004
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Intracellular Cytokine Staining (ICS) Assay
All intracellular cytokine staining (ICS) assays were carried out
on freshly isolated PBMCs. Purified PBMCs were resuspended at
16107 cells/ml in complete RPMI 1640 medium and were then
aliquoted (16106 cells) at 200 ml to each well in the 96-well U-
bottom plates (Costar Inc., NY). PBMCs were stimulated with 8
pools of overlapping peptides (2 mg/ml final concentration for
each individual constituent peptide final concentration) spanning
expressed HIV-1 gene products (Gag1, Gag2, Pol4, Pol5, Env2,
Env3, Nef, and a combined pool of Tat and Rev), and
costimulatory antibodies (anti-CD28 and anti-CD49d at a final
concentration of 1 mg/ml each) and CD107a-Cy5-PE (pre-titered
Figure 5. Correlations between CD8+ T-cell functionalities and blood CD4+ T-cell counts or plasma viral loads during early chronic
HIV-1 infections. a. Correlation between the CD8+ T-cell functionalities and blood CD4+T-cell counts or plasma viral load for triple producers (TP),
double producers (DP), and single producers (SP) of Gag2-specific responses in early chronic HIV-1-infected individuals. b. Different functional HIV-
specific CD8+ T cells associated with good clinical outcomes (good clinical outcomes indicated an inverse correlation between the magnitude of HIV-
specific CD8+ T-cell responses and viral loads, or a positive correlation between the magnitude of HIV-specific CD8+ T-cell responses and CD4+ T-cell
counts). Results from linear regression model analysis on the magnitude of eight HIV-peptide pool specific responses against blood CD4+ T-cell
counts or plasma viral loads during early chronic HIV-1 infections. Each dot denoted a positive response for the function indicated at the bottom left.
doi:10.1371/journal.pone.0044983.g005
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volume) were added to the cells. Cells were incubated for 6 hours
at 37uC in the presence of 5% CO2, and the secretion inhibitor
brefeldin A (final concentration of 10 mg/ml, Sigma) was added to
the cultures from the second hour of incubation. A negative
control (peptide-free medium plus 0.05% DMSO and costimula-
tory antibodies) and a positive control (stimulated with PMA and
ionomycin at a final concentration of 50 ng/ml and 1 mg/ml,
respectively; Sigma) were included in each assay.
Following incubation, the cells were washed with phosphate-
buffered saline (PBS)-2% FBS and stained with surface antibodies
(CD3-ECD, CD4-Cy7-APC and CD8-AmCyan) for 30 min at
4uC in the dark. Cells were then washed again, fixed and
permeabilized using the Cytofix/Cytoperm kit (BD PharMingen)
according to instructions. Following fixation, the cells were washed
twice in the perm buffer and stained with antibodies against
intracellular markers. Cells were then incubated for 30 min at 4uC
with a cocktail of four anti-human monoclonal antibodies
conjugated to different fluorochromes for the detection of
cytokines (IL-2-PE, MIP-1b-FITC, TNF-a-APC and IFN-c-
Pacific Blue). Following staining, the cells were washed, fixed
(PBS containing 1% paraformaldehyde), and stored at 4uC until
analysis (within 24 h) in a modified FACSAriaTM flow cytometer
(BD Immunocytometry System).
Flow Cytometry Analyses
Data acquisition and analysis was performed using the BD
FACSDiva software. Instrument settings and fluorescence com-
pensation were performed for each day of testing by using
unstained and single fluorochromes-stained samples. Stimulated
cells stained with surface molecules and isotype controls
corresponding to intracellular markers were included for each
patient in order to accurately set negative populations. Lympho-
cyte gating was performed on small cells in a forward scatter (FSC)
versus side scatter (SSC) plot. Between 200,000 and 500,000
events were acquired in the lymphocyte gate. CD3+ events were
gated in an FSC versus CD3 plot prior to gating on CD4 versus
CD8, and CD3+CD4-CD8+ cells were considered to be CD8+T
cells. Following identification of CD8+T cells, individual gating
was performed for each studied function and their combinations.
For this purpose, ‘‘derived gating tools’’ available at the
FACSDiva software was used. To study double- and triple-
positive populations (cell subsets with four or five functions were
practically absent), intersections of two and three gates were
created, respectively. Data presented correspond to background-
subtracted results by using the anti-CD28/49d stimulation alone
as background. This was performed on a cytokine subset by
cytokine subset basis, i.e., subtracting the result from the ‘‘CD28/
49d-only’’ for a given cytokine subset to the same subset of a
peptide-stimulated condition.
Statistical Analysis
Unless otherwise noted, net antigen-specific responses were
calculated by subtracting values for the negative control (medium
plus costimulatory antibodies) from antigen-specific responses. A
positive response threshold was set at 50 SFCs/106 PBMCs and
0.05% of CD8+ T cells in the Elispot assay and ICS assay,
respectively. In ICS assay, values below this level, after subtraction
of negative control values, were set to zero [15]. Statistical analyses
were performed using GraphPad Prism 5 for Windows (GraphPad
Software, La Jolla, CA). All data were analyzed using Mann–
Whitney U tests of nonparametric statistics. Correlations were
determined using Spearman’s rank test. All tests were considered
significant if the p value obtained was less than 0.05.
Supporting Information
Figure S1 Comparison of the magnitude of CD8+ T cell
responses to each peptide pools per individual between groups.
Elispot assays were used to determine the magnitude of CD8+ T
cell responses. Filled circles were used for early chronic HIV-
infected subjects and open circles for primary HIV-infected
subjects; The SFCs from control settings were deducted from
experimental setting and therefore the spots shown in this figure
were ‘‘net’’ SFCs for comparison. Statistically significant differ-
ences between groups (p,0.05) were denoted by a line with an
asterisk, and p,0.01 for double asterisks. The median magnitude
for each group are indicated as horizontal black lines. The p value
was calculated by using a nonparametric Mann–Whitney test.
(TIFF)
Figure S2 Gating scheme used for the identification of CD8+ T-
cell responses. Data shown were from cells derived from one
representative patient, stimulated with Gag 1 peptide pool. Initial
gating was performed on lymphocytes in a forward scatter of FSC-
A versus FSC-H, and then FSC vs SSC plot. CD3+ events were
gated in the FSC versus CD3 plot prior to gating on CD3+CD8+
and CD3+CD4+ events. The resulting CD3+CD4-CD8+ popula-
tion was further gated based on positivity for each of 5 functional
responses including IL-2, MIP-1b, CD107a, TNF-a and IFN-c.
(TIFF)
Figure S3 Comparison of the magnitude of CD8+ T cell
responses to each peptide pools between groups. Intracellular
staining assays were used to determine the magnitude of CD8+ T
cell responses. Statistically significant differences between groups
(p,0.05) were denoted by a line with an asterisk, and p,0.01 for
double asterisks and p,0.001 for three asterisks. The median
magnitudes for each group were indicated as horizontal black
lines. The p value was calculated by using a nonparametric
Mann–Whitney test.
(TIFF)
Figure S4 Gating scheme used for the identification of different
functional CD8+ T-cell subpopulations. Data shown were from
one representative patient, stimulated with PMA plus Ionomycin
(positive control). Cells collected from diagonal line in FSC-A vs
FSC-H plot were used for subsequent analysis, both CD3 and
CD8 surface markers were employed to determine CD8+ T-cell
population. Different functional CD8+ T cells were determined as
followings: IFN-c was firstly tested, and then both IFN-c positive
and negative cells were further determined on the plot of TNF-
alpha vs MIP-1belta, finally all four populations from the plot of
TNF-alpha vs MIP-1belta were tested on the plot of IL-2 vs
CD107a. The percentage for each functional CD8+ T cell
population was calculated against CD8+ T cells, eg. IFN-




We acknowledge NIH AIDS Research and Reference Reagent Program
for the provision of peptides, and we are very grateful to all of the patients
who contributed to the study.
Author Contributions
Conceived and designed the experiments: JQX XYZ. Performed the
experiments: WHW CQ CLQ. Analyzed the data: WHW JQX.
Contributed reagents/materials/analysis tools: YW XYZ JQX. Wrote
the paper: WHW JQX.
CD8+ T Cell Functionality in HIV+ MSM
PLOS ONE | www.plosone.org 12 September 2012 | Volume 7 | Issue 9 | e44983
References
1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB (1994) Virus-specific
CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in
primary human immunodeficiency virus type 1 infection. J Virol 68: 6103–6110.
2. Jin X, Bauer DE, ETuttleton S, Lewin S, Gettie A, et al. (1999) Dramatic rise in
plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-
infected macaques. J Exp Med 189: 991–998.
3. Price DA, Goulder PJ, Klenerman P, KSewell A, Easterbrook PJ, et al. (1997)
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during
primary infection. Proc Natl Acad Sci USA 94: 1890–1895.
4. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, et al. (1997) Late
escape from an immunodominant cytotoxic T-lymphocyte response associated
with progression to AIDS. Nat Med 3: 212–217.
5. Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, et al. (2006)
CTL escape and increased viremia irrespective of HIV-specific CD4+T-helper
responses in two HIV-infected individuals. Virology 345: 209–219.
6. Carrington M, O’Brien SJ. (2003) The influence of HLA genotype on AIDS.
Annu Rev Med 54: 535–551.
7. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, et al.
(2000) HLA B*5701 is highly associated with restriction of virus replication in a
subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA
97: 2709–2714.
8. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, et al. (2003) Influence
of HLA-B57 on clinical presentation and viral control during acute HIV-1
infection. AIDS 17: 2581–2591.
9. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, et al. (2001)
Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and
CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
J Virol 75: 11983–11991.
10. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, et al. (2003)
Comprehensive epitope analysis of human immunodeficiency virus type 1
(HIV-1)-specific T-cell responses directed against the entire expressed HIV-1
genome demonstrate broadly directed responses, but no correlation to viral load.
J Virol 77: 2081–2092.
11. Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, et al. (2004)
Hierarchical targeting of subtype C human immunodeficiency virus type 1
proteins by CD8+ T cells: correlation with viral load. J Virol 78: 3233–3243.
12. Julg B, Williams KL, Reddy S, Bishop K, Qi Y, et al. (2010) Enhanced anti-HIV
functional activity associated with Gag-specific CD8 T-cell responses. J Virol 84:
5540–5549.
13. Mothe B, Llano A, Ibarrondo J, Zamarreño J, Schiaulini M, et al. (2012) CTL
responses of high functional avidity and broad variant cross-reactivity are
associated with HIV control. PLoS One 7: e29717.
14. Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel AG, et al. (2004) Persistent
recognition of autologous virus by high-avidity CD8 T cells in chronic,
progressive human immunodeficiency virus type 1 infection. J Virol 78: 630–
641.
15. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV
nonprogressors preferentially maintain highly functional HIV-specific CD8+ T
cells. Blood 107: 4781–4789.
16. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, et al. (2008) Antigen
load and viral sequence diversification determine the functional profile of HIV-
1-specific CD8+ T cells. PLoS Med 5: e100.
17. Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, et al. (2007)
Sequential broadening of CTL responses in early HIV-1 infection is associated
with viral escape. PLoS One 2: e225.
18. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, et al. (2007) Superior
control of HIV-1 replication by CD8+ T cells is reflected by their avidity,
polyfunctionality, and clonal turnover. J Exp Med 204: 2473–2485.
19. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, et al. (2008) HLA class I
restricted T-cell responses may contribute to the control of human immuno-
deficiency virus infection, but such responses are not always necessary for long
term virus control. J Virol 82: 5398–5407.
20. Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, et al. (2005) Phenotypic,
functional, and kinetic parameters associated with apparent T-cell control of
human immunodeficiency virus replication in individuals with and without
antiretroviral treatment. J Virol 79: 14169–14178.
21. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, et al. (2005) HIV-1-
specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent
proliferation of HIV-1-specific CD8 T cells. Proc Natl Acad Sci USA 102: 7239–
7244.
22. Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, et al. (2010) Perforin
expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV
elite control. PLoS Pathog 6: e1000917.
23. Jones N, Eggena M, Baker C, Nghania F, Baliruno D, et al. (2006) Presence of
distinct subsets of cytolytic CD8+T cells in chronic HIV infection. AIDS Res
Hum Retroviruses 22: 1007–1013.
24. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC (2002) Compromised
influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice.
J Virol 76: 12388–12393.
25. Lichterfeld M, Kaufmann DE, Yu XG, Mui SK, Addo MM, et al. (2004) Loss of
HIV-1-specific CD8+T cell proliferation after acute HIV-1 infection and
restoration by vaccine-induced HIV-1-specific CD4+T cells. J Exp Med 200:
701–712.
26. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, et al. (2000) Impaired
function of circulating HIV-specific CD8(+) T cells in chronic human
immunodeficiency virus infection. Blood 96: 3094–3101.
27. Goulder PJ, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, et al. (2001)
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute
and chronic HIV infection. J Exp Med 193: 181–194.
28. Kloverpris H, Karlsson I, Bonde J, Thorn M, Vinner L, et al. (2009) Induction
of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by
immunization with subdominant cytotoxic T-lymphocyte epitopes. AIDS 23:
1329–1340.
29. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, et al. (2009)
The first T cell response to transmitted/founder virus contributes to the control
of acute viremia in HIV-1 infection. J Exp Med 206: 1253–1272.
30. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. (2010)
The immune response during acute HIV-1 infection: clues for vaccine
development. Nat Rev Immunol 10: 11–23.
31. Nowak MA, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, et al. (1995)
Antigenic oscillations and shifting immunodominance in HIV-1 infections.
Nature 375: 606–611.
32. Turnbull EL, Wong M, Wang S, Wei X, Jones NA, et al. (2009) Kinetics of
expansion of epitope-specific T cell responses during primary HIV-1 infection.
J Immunol 182: 7131–7145.
33. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, et al. (2007) Selective
depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific
CD8+ T cells after early HIV-1 infection. J Virol 81: 4199–214.
34. Streeck H, Schweighardt B, Jessen H, Allgaier RL, Wrin T, et al. (2007) Loss of
HIV-1-specific T-cell responses associated with very rapid HIV-1 disease
progression. AIDS 21: 889–891.
35. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, et al. (2005) HIV-1-
specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent
proliferation of HIV-1-specific CD8 T cells. PNAS 102: 7239–7244.
36. Wang W, Xu J, Jiang S, Yang K, Meng Z, et al. (2011) The dynamic face of
HIV-1 subtypes among men who have sex with men in Beijing, China. Curr
HIV Res. 9: 136–9.
37. Zhang X, Huang X, Xu J, Li S, Jiang S, et al. (2006) HIV-specific T cell
immunity across the entire HIV genome in Chinese men who have sex with
men. Chin Med J (Engl) 119: 1958–1965.
CD8+ T Cell Functionality in HIV+ MSM
PLOS ONE | www.plosone.org 13 September 2012 | Volume 7 | Issue 9 | e44983
